NYL reports consulting or advisory roles for Eli Lilly, EMD Serono (an affiliate of Merck KGaA, Darmstadt, Germany), Merck KGaA, Pfizer, Sanofi-Aventis, and UpToDate; and has received research funding for clinical trials from AstraZeneca, EMD Serono, and Pfizer. RLF reports consulting or advisory roles for Aduro Biotech, AstraZeneca–MedImmune, Bristol Myers Squibb, EMD Serono, GlaxoSmithKline, Iovance Biotherapeutics, MacroGenics, Merck KGaA, Nanobiotix, Novasenta, Numab Therapeutics, Oncorus, Ono Pharmaceutical, Pfizer, PPD (Benetec, Immunicum), Regeneron Pharmaceuticals, and Torque Therapeutics; has received research funding from AstraZeneca–MedImmune, Bristol Myers Squibb, Merck KGaA, Novasenta, and Tesaro; has received reimbursement for travel expenses from Ono Pharmaceutical; and owns stock in Novasenta. SDB reports employment at Pfizer. EC reports consulting or advisory roles for ALX Oncology, Ascendis Pharma, Bayer, BioLineRx, Bristol Myers Squibb, Debiopharm, Dynavax Technologies, Merck KGaA, Merck & Co, Regeneron Pharmaceuticals, and Sanofi. Medical writing assistance was provided by Eleanor Green at ClinicalThinking, funded by Pfizer and Merck KGaA.